Inventor · disambiguated record
Jennitte Leann Stevens
Also filed as: STEVENS JENNITTE · STEVENS JENNITTE LEANN
7 granted patents·13 pending applications·15 citations·filing 2012–2025
79Inventor score
Top patents by PatentIndex Score
20 records- 0193US11530274B2Anti-STEAP1 antigen-binding proteinAMGEN INC·Filed 2019·Granted Dec 20, 2022·8 cites·72 claims
- 0283US11466079B2C-terminal antibody variantsAMGEN INC·Filed 2019·Granted Oct 11, 2022·3 cites·25 claims
- 0381US11248052B2Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorAMGEN INC·Filed 2019·Granted Feb 15, 2022·1 cites·5 claims
- 0481US2024301087A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2024·Application pending·0 cites
- 0576US9574002B2Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorLI YANG·Filed 2012·Granted Feb 21, 2017·2 cites·14 claims
- 0676US2023159656A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2022·Application pending·0 cites
- 0773US11858983B2C-terminal anti-sclerostin antibody variantsAMGEN INC·Filed 2022·Granted Jan 2, 2024·0 cites·24 claims
- 0871US2025353899A1Engineering monoclonal antibodies to improve stability and production titerAMGEN INC·Filed 2025·Application pending·0 cites
- 0969US2025154281A1Anti-steap1 antigen-binding proteinAMGEN INC·Filed 2025·Application pending·0 cites
- 1063US10202616B2Promoter and regulatory elements for improved expression of heterologous genes in host cellsAMGEN INC·Filed 2015·Granted Feb 12, 2019·1 cites·10 claims
- 1161US2025282869A1Heteromultimer binding dll3 and cd3AMGEN INC·Filed 2023·Application pending·0 cites
- 1258US2023174995A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1358US2023183382A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1456US2022144920A1Engineering monoclonal antibodies to improve stability and production titerAMGEN INC·Filed 2020·Application pending·0 cites
- 1555US2022089689A1Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methodsAMGEN INC·Filed 2021·Application pending·0 cites
- 1652US2017183412A1Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF ReceptorAMGEN INC·Filed 2017·Application pending·0 cites
- 1749US2024209115A1Methods for reducing low molecular weight species of recombinantly-produced proteinsAMGEN INC·Filed 2022·Application pending·0 cites
- 1841US2022228102A1Data-driven predictive modeling for cell line selection in biopharmaceutical productionAMGEN INC·Filed 2020·Application pending·0 cites
- 1940US11149078B2Variants of tissue inhibitor or metalloprotienase type three (TIMP-3), compositions and methodsAMGEN INC·Filed 2015·Granted Oct 19, 2021·0 cites·27 claims
- 2040US2018305465A1Heterodimeric antibodies that bind cd3 and cd38AMGEN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennitte Leann Stevens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →